ArticleTranslational vision science & technology2025
Radiomics-Based OCT Analysis of Choroid Reveals Biomarkers of Central Serous Chorioretinopathy.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Radiomics-based fundus autofluorescence analysis in central serous chorioretinopathy-MICRoN report number twelve.Scientific reports · 2026Article
- Reproducibility of Optical Coherence Tomography Radiomics after Cataract Surgery: Effects of Media Opacity, Signal Strength, and Region of Interest Selection.Korean journal of ophthalmology : KJO · 2026Article
- Radiomics-Based Fundus Photography Analysis in Diabetic Retinopathy.Translational vision science & technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Purpose: Biomarkers from choroidal imaging can enhance clinical decision-making for chorioretinal disease; however, identification of biomarkers is labor-intensive and limited by human intuition. Here we apply radiomics feature extraction to choroid imaging from swept-source optical coherence tomography (SS-OCT) to automatically identify biomarkers that distinguish healthy, central serous chorioretinopathy (CSCR), and unaffected fellow eyes. Methods: Radiomics features were extracted from SS-OCT images from healthy (n = 30), CSCR (n = 39), and unaffected fellow eyes (n = 20), with a total of 44,500 single-cross sectional horizontal images and 8900 en face images. Logistic regression classification of eyes as healthy versus CSCR, healthy versus fellow, or CSCR versus fellow was performed using radiomics features. Statistical significance was determined using 95% bootstrap confidence intervals. Results: Significant differences between healthy and CSCR eyes were found for all radiomics feature groups. Classification of health versus CSCR achieved classification accuracy of 84.2% (77.2%-89.9%) in horizontal images and 85.3% (78.2%-90.7%) in en face images. For en face images, classification accuracy increased by 1.02% (0.50%-1.53%) for every 10% increase in choroid depth. Fellow eye classification using a classifier trained to distinguish healthy and CSCR eyes resulted in 90.4% (90.2%-90.6%) of horizontal images and 90.2% (89.8%-90.2%) of en face images being classified as CSCR. Conclusions: These results demonstrate accurate classification of healthy and CSCR eyes using choroid OCT radiomics features. Furthermore, radiomics features revealed signatures of CSCR in unaffected fellow eyes. Translational Relevance: These findings demonstrate the potential for radiomics features in clinical decision support for CSCR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.